- US-listed companies
- Edwards Lifesciences Corp
- Balance sheet
Edwards Lifesciences Corp【EW】Balance sheet
Market cap
$49.9B
P/E ratio
| 2010/12 | 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Cash and cash equivalents | 396 | 171 | 311 | 420 | 654 | 718 | 930 | 818 | 714 | 1,179 | 1,200 | 867 | 773 | 1,148 | 3,059 |
| Marketable securities, current | - | - | - | - | 785 | 506 | 341 | 519 | 242 | 338 | 219 | 604 | 446 | 501 | 931 |
| Total cash & short-term investments | 396 | 171 | 311 | 420 | 1,439 | 1,225 | 1,271 | 1,338 | 957 | 1,517 | 1,420 | 1,471 | 1,219 | 1,649 | 3,990 |
| Accounts receivable, net | 277 | 284 | 321 | 303 | 288 | 315 | 366 | 422 | 457 | 544 | 515 | 582 | 643 | 775 | 609 |
| Inventories | 204 | 261 | 281 | 309 | 297 | 340 | 397 | 555 | 607 | 641 | 802 | 727 | 876 | 1,168 | 1,087 |
| Total current assets | 1,033 | 1,169 | 1,292 | 1,726 | 2,295 | 2,048 | 2,240 | 2,532 | 2,287 | 2,984 | 3,091 | 3,181 | 3,096 | 4,036 | 6,285 |
| Property, plant and equipment, net | 270 | 304 | 373 | 422 | 443 | 483 | 580 | 680 | 868 | 1,060 | 1,395 | 1,547 | 1,633 | 1,749 | 1,686 |
| Marketable securities, non-current | 25 | 22 | 21 | 22 | 241 | 380 | 532 | 567 | 506 | 586 | 802 | 1,834 | 1,239 | 584 | 308 |
| Total non-current assets | 735 | 812 | 930 | 999 | 1,230 | 2,011 | 2,270 | 3,164 | 3,037 | 3,504 | 4,146 | 5,322 | 5,197 | 5,328 | 6,770 |
| Total assets | 1,767 | 1,981 | 2,222 | 2,725 | 3,524 | 4,059 | 4,510 | 5,696 | 5,324 | 6,488 | 7,237 | 8,503 | 8,293 | 9,363 | 13,055 |
| Accounts payable | 48 | 85 | 75 | 48 | 58 | 64 | 97 | 117 | 134 | 180 | 197 | 205 | 202 | 201 | 197 |
| Long-term debt, current | - | - | - | - | - | - | - | 598 | - | - | - | - | - | - | - |
| Total current liabilities | 338 | 335 | 347 | 346 | 434 | 476 | 533 | 1,403 | 877 | 902 | 894 | 1,032 | 1,022 | 1,195 | 1,505 |
| Long-term debt, non-current | - | - | - | 593 | 598 | 600 | 822 | 438 | 594 | 594 | 595 | 596 | 596 | 597 | 598 |
| Total non-current liabilities | - | - | - | - | - | - | - | - | - | - | - | 1,634 | 1,463 | 1,448 | 1,487 |
| Total liabilities | - | - | - | - | - | - | - | - | - | - | - | 2,667 | 2,486 | 2,644 | 2,992 |
| Common stock and paid-in capital | 328 | 120 | 124 | 126 | 129 | 239 | 243 | 212 | 215 | 218 | 636 | 642 | 646 | 651 | 655 |
| Retained earnings | 1,124 | 1,361 | 1,654 | 2,046 | 2,842 | 3,337 | 3,906 | 1,962 | 2,695 | 3,742 | 4,565 | 6,068 | 7,590 | 8,992 | 13,167 |
| Stockholders' equity | 1,308 | 1,338 | 1,479 | 1,559 | 2,191 | 2,503 | 2,619 | 2,956 | 3,140 | 4,148 | 4,574 | 5,836 | 5,807 | 6,719 | 10,063 |
| Total debt | - | - | - | 593 | 598 | 597 | 822 | 1,036 | 594 | 594 | 595 | 596 | 596 | 597 | 598 |
| Net debt | - | - | - | 173 | -841 | -628 | -449 | -301 | -363 | -922 | -825 | -876 | -623 | -1,051 | -3,392 |
| D/E ratio (%) | - | - | - | 38 | 27.3 | 23.8 | 31.4 | 35.1 | 18.9 | 14.3 | 13 | 10.2 | 10.3 | 8.9 | 5.9 |
| Working capital |